Hepatitis Clinical Trials

Showing 681-700 of 1,819 trials

Proof of Concept Study to Determine the Safety and Antiviral Effect of BZF961 With or Without Ritonavir Boosting in Hepatitis C Virus Infected Patients

NCT01825980

To evaluate the antiviral activity of 3 days of BZF961. To determine safety and tolerability of BZF961 in HCV patients. To evaluate pharmacokinetics of BZF961 in HCV patients.

Hepatitis C

Novartis Pharmaceuticals54 participantsStarted Mar 2013

San Diego, California, United States • Orlando, Florida, United States • San Antonio, Texas, United States

COMPLETEDNA

Evaluation of HIV-1, HCV and HBV Blood Screening Tests With Human Blood Donor Specimens

NCT00552214

The purpose of this study is to validate the performance characteristics of an assay that tests for HIV-1, HCV and HBV on an automated blood bank instrument for registration submission.

Screening for the Presence of HIV-1, RNA and HBV DNA in Blood Donations

Novartis10,290 participantsStarted Aug 2007

Taipei, Taiwan

COMPLETED

Evaluation of Liver Fibrosis With 2D-Shear Wave Elastography

NCT04759521

The aims of this study are to evaluate liver fibrosis with two-dimensional (2D) shear wave elastography (SWE) technique in inactive hepatitis B surface antigen (HBsAg) carriers and patients with active chronic hepatitis B (CHB), with the help of a propagation map, compare this method with histopathological results in patients with CHB and determine the suitability of 2D-SWE for use instead of liver biopsy by evaluating fibrosis before and after treatment.

Chronic Hepatitis BSonoelastographyFibrosis, Liver

Seyhmus Kavak253 participantsStarted Jan 2019

Diyarbakır, Turkey (Türkiye)

Proof of Concept Study to Determine the Safety and Antiviral Effect of BZF961 With or Without Ritonavir Boosting in Hepatitis C Virus Infected Patients

Evaluation of HIV-1, HCV and HBV Blood Screening Tests With Human Blood Donor Specimens

Evaluation of Liver Fibrosis With 2D-Shear Wave Elastography

Related Searches

A Study Evaluating ABI-H0731 as Adjunctive Therapy in Participants With Chronic Hepatitis B Infection

Addressing the Cascade of Care in Vulnerable Populations With Poor Access to Healthcare in Madrid

A Study of Vaniprevir (MK-7009) in Participants With Chronic Hepatitis C Infection After Participation in Other Vaniprevir Studies (MK-7009-028)

The Effect of Boceprevir in Russian Participants Diagnosed With Chronic Hepatitis C Genotype 1 (P08160)

The Sublimated Mare Milk Supplement in Hepatitis C

Safety and Efficacy of Therapeutic Hepatitis B Adenovirus Injection (T101) Combined With Nucleoside (Acid) Analogues in Chronic Hepatitis B Patients

A Study of the Combination Regimen Grazoprevir (MK-5172) and Elbasvir (MK-8742) ± Ribavirin in Participants With Chronic Hepatitis C (MK-5172-035)

Safety and Tolerability of Novel Medical Nutrition Products for NAFLD Treatment

Efficacy and Safety of Uprifosbuvir (MK-3682) + Ruzasvir (MK-8408) in Treating Hepatitis C Virus Infection Genotypes 1-6 (MK-3682-041)

Sofosbuvir Based DAA Therapy in HIV/HCV Coinfected Pre or Post Liver Transplant

Efficacy and Safety of Boceprevir in Combination With Peginterferon Alfa-2b Plus Ribavirin in Pediatric Subjects With Chronic Hepatitis C Genotype 1 (P08034)

A Study of ABI-H2158 in Healthy Volunteers and Patients With Chronic Hepatitis B

The Phase III Study of Icaritin Versus HUACHANSU PIAN in Hepatocellular Carcinoma Subjects

Evaluation of the Use of the GenXpert to Detect Hepatitis C RNA

TD-6450 MAD Study in HCV Infected Subjects

Study to Evaluate Antibody Persistence in Children Previously Vaccinated With Infanrix Hexa™ or Infanrix-IPV/Hib™

Current Treatment of HCV Infection After HSCT